Meeting on the Med 2021 | Horizon scanning for the UK cell & gene therapy sector

Stephen Ward, PhD, Cell and Gene Therapy Catapult, London, UK, provides an overview of the current cell and gene therapy landscape in the UK and looks ahead to the future. The UK’s cell and gene therapy sector currently receives a high level of support from the UK government which has helped to drive product development, manufacturing capability and adoption into healthcare systems. Going forward, Dr Ward expects the sector to continue to build on the strong infrastructure already in place in the UK and take advantage of innovation platforms and manufacturing facilities. This interview took place during the Cell & Gene Meeting on the Mediterranean 2021 virtual conference.